Bienta

Bienta is a trademark for preclinical biology services of Enamine, the worlds largest supplier of drug-like molecules for drug discovery research. Bienta is operating as a Contract Research Organisation (CRO) providing biomolecular screening (HTS) services as well as comprehensive bioanalytical support for drug discovery projects, including in vitro ADMET (absorption, distribution, metabolism, excretion, toxicity) testing as well as pharmacokinetics (PK) and toxicity studies in animals

Cro,drug discovery,admet,pharmacokinetics,animal studies,life sciences,biotechnology,pharmaceuticals,medicinal chemistry,preclinical studies,molecular modeling,hts,virtual screening,chemoinformatics,cell culture,recombinant protein expression,high throughput screening,adme/dmpk,mass spectrometry,bioanalytical services,assay development,toxicity testing,metabolism,toxicology,and adme-tox

Bienta operates in the Research industry.

Bienta's revenue is 11m - 100m

Bienta has 11 - 50 employees.